March 2022: First Clinical Trial Registered and Publicly Available on CTIS

Tiohundra AB becomes the first sponsor to successfully register a clinical trial on European Union Clinical Trial Information System (EU CTIS).

Vasopressin and Steroids in addition to Adrenaline in cardiac arrest -a randomized clinical trialis an ongoing phase III trial submitted on February 28, 2022, and the decision was made on March 28, 2022. This study was previously approved and registered on The details that are available in the public domain for this study are study summary, trial-specific information, and country-specific information. The documents that are public include the cover letter, protocol, investigator brochure, summary of product characteristics, proof of payment, trial and researcher information, and investigator curriculum vitae (CV).

The trial information is accessible via the Search results tab of the Search for clinical trials option.